These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23573962)

  • 1. Antihyperalgesic effects of a novel muscarinic agonist (LASSBio-873) in spinal nerve ligation in rats.
    Mendes TC; Antunes F; Trachez MM; Nascimento NM; Fraga CA; Barreiro EJ; Zapata-Sudo G; Sudo RT
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):404-11. PubMed ID: 23573962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors.
    Mendes TC; Raimundo JM; Nascimento-Junior NM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Pharmacol Biochem Behav; 2009 Nov; 94(1):70-4. PubMed ID: 19635495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic agonists in the treatment of neuropathic pain: a novel finding.
    Deng L; Guindon J
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):395-7. PubMed ID: 23701118
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-emptive intrathecal quinidine alleviates spinal nerve ligation-induced peripheral neuropathic pain.
    Cheng KI; Wang HC; Lai CS; Tsai HP; Kwan AL; Ho ST; Wang JJ; Chang LL
    J Pharm Pharmacol; 2011 Aug; 63(8):1063-9. PubMed ID: 21718290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain.
    Hopkins SC; Zhao FY; Bowen CA; Fang X; Wei H; Heffernan ML; Spear KL; Spanswick DC; Varney MA; Large TH
    J Pharmacol Exp Ther; 2013 Jun; 345(3):502-11. PubMed ID: 23520265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer N-phthaloyl GABA derivatives with antiallodynic and antihyperalgesic activities in both sciatic nerve and spinal nerve ligation models of neuropathic pain.
    Yogeeswari P; Ragavendran JV; Sriram D; Kavya R; Vanitha K; Neelakantan H
    Pharmacology; 2008; 81(1):21-31. PubMed ID: 17785996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
    Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
    Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
    Holdridge SV; Cahill CM
    Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral alpha4beta2 nicotinic acetylcholine receptor signalling attenuates tactile allodynia and thermal hyperalgesia after nerve injury in mice.
    Saika F; Kiguchi N; Kobayashi Y; Kishioka S
    Acta Physiol (Oxf); 2015 Feb; 213(2):462-71. PubMed ID: 25491757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihyperalgesic effect of 5-HT7 receptor activation on the midbrain periaqueductal gray in a rat model of neuropathic pain.
    Li SF; Zhang YY; Li YY; Wen S; Xiao Z
    Pharmacol Biochem Behav; 2014 Dec; 127():49-55. PubMed ID: 25450118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons.
    Hagenacker T; Schäfer N; Büsselberg D; Schäfers M
    Eur J Pain; 2013 Jul; 17(6):881-92. PubMed ID: 23229998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats.
    Werner MF; Kassuya CA; Ferreira J; Zampronio AR; Calixto JB; Rae GA
    Neuropharmacology; 2007 Jul; 53(1):48-57. PubMed ID: 17555775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of tramadol with minocycline exerted synergistic effects on a rat model of nerve injury-induced neuropathic pain.
    Mei XP; Chen L; Wang W; Wu D; Wang LY; Zhang T; Zhang H; Xu LX; Li YQ
    Neurosignals; 2013; 21(3-4):184-96. PubMed ID: 22964800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
    Lee HG; Park SK; Yoon MH
    Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal P2X(7) receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model.
    He WJ; Cui J; Du L; Zhao YD; Burnstock G; Zhou HD; Ruan HZ
    Behav Brain Res; 2012 Jan; 226(1):163-70. PubMed ID: 21933684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitecapone reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats.
    Kambur O; Männistö PT; Pusa AM; Käenmäki M; Kalso EA; Kontinen VK
    Eur J Pain; 2011 Aug; 15(7):732-40. PubMed ID: 21216640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
    Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
    Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect and underlying mechanisms of spirocyclopiperazinium salt compound DXL-A-24 in rats following spinal nerve ligation.
    Liu Q; Gao X; Wang T; Wang X; Li R; Jiang Y; Ye J
    Brain Res; 2023 Feb; 1800():148187. PubMed ID: 36463957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain.
    Lima CK; Silva RM; Lacerda RB; Santos BL; Silva RV; Amaral LS; Quintas LE; Fraga CA; Barreiro EJ; Guimaraes MZ; Miranda AL
    PLoS One; 2014; 9(6):e99510. PubMed ID: 24941071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central pituitary adenylate cyclase 1 receptors modulate nociceptive behaviors in both inflammatory and neuropathic pain states.
    Davis-Taber R; Baker S; Lehto SG; Zhong C; Surowy CS; Faltynek CR; Scott VE; Honore P
    J Pain; 2008 May; 9(5):449-56. PubMed ID: 18337184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.